NFKB1 and esophageal squamous cell carcinoma: Notably, the treatment with PS1145, a specific small-molecule IKK inhibitor, efficiently blocked the promotion of EMT transcription factor expression, cell migration, and invasion induced by TMEM26, demonstrating the indispensable role of NF-κB signaling in the EMT of ESCC cells.